Cognitive, Emotional, Physical, and Psychosocial Effects of Three Weeks' Prospective Double-Blind Placebo Controlled Cross-Over Exposure to Panax Quinquefolius L (REMEMBER-fX), With Optional Six Months' Open Label Follow-up

NCT00527969 Phase 2 COMPLETED

The purpose of this study is to determine the efficacy and safety of REMEMBER-fX (HT1001, an extract of Panax quinquefolius) in a human sample using standard clinical neuropsychological instruments and side effects rating scales.

Details

Lead sponsor	CV Technologies
Phase	Phase 2
Status	COMPLETED
Enrolment	72
Start date	2007-07

Conditions

• Memory
• Learning
• Attention
• Cognition
• Well-Being

Interventions

• HT1001 extract of Panax quinquefolius L

Primary outcomes

• Use of HT1001 will improve objective measures of psychomotor speed, sustained attention, working memory, declarative memory, and or executive skills. — 3 weeks

Countries

Canada